Global Market Study on Hepatitis C Treatment

Nov 2016| PMR089A| Persistence Market Research

Report Highlights

In this report, Persistence Market Research (PMR) offers an eight year forecast of the global hepatitis C treatment market between 2016 and 2024. The current study reveals the market trends and market dynamics that are expected to positively affect the current market environment and future scenario of the hepatitis C treatment market over the forecast period.

This report covers the global hepatitis C treatment market performance in terms of revenue contribution. The report includes key trends, drivers, restraints, and opportunities influencing growth of the global hepatitis C treatment market. Impact analysis of key growth drivers and restraints, based on the weighted average model, are included to better equip clients with crystal clear decision-making insights.

The global hepatitis C treatment market report begins with the executive summary and definitions of various categories and their usage in various industries. It is followed by market overview of the global hepatitis C treatment market, which includes PMR’s analysis of market trends, drivers, restraints and opportunities that are affecting growth of the global hepatitis C treatment market. Furthermore, to understand the popularity of the market segment and regions, the attractiveness index with elaborated insights on the same is provided, which will show the market’s attractiveness based on factors such as CAGR and incremental $ opportunity.

On the basis of drug class, hepatitis C treatment market is segmented into HCV Protease Inhibitors, HCV Polymerase Inhibitors, HCV NS5A Inhibitors, Combination Therapy and Interferon & Antiviral, which is again sub-divided into various drugs sub segments. By distribution channel, hepatitis C treatment market is segmented into hospital pharmacies, retail pharmacies and online pharmacies.

In the final section of the report on global hepatitis C treatment market, the ‘dashboard view’ of the companies is provided to compare the current industrial scenario and their contribution to the total hepatitis C treatment market. Moreover, it is primarily designed to provide clients with an objective and detailed comparative assessment of key providers specific to a market segment. Report audiences can gain segment-specific manufacturer insights to identify and evaluate key competitors based on an in-depth assessment of their capabilities and success in the hepatitis C treatment marketplace.

Research methodology

To ascertain the global hepatitis C treatment market size, we have taken into account the revenue generated by the various hepatitis C treatment drug manufacturers globally. The forecast presented here assesses the total revenue generated by value across the global hepatitis C treatment market. In order to provide an accurate forecast, we initiated by sizing up the current market, which forms the basis on how the hepatitis C treatment market is expected to develop in the future. Given the characteristics of the market, we triangulated the outcome on the basis of three different types of analysis; based on supply side, downstream industry demand and the economic envelope.

In addition, it is imperative to note that in an ever-fluctuating global economy, we not only conduct forecasts in terms of CAGR, but also analyze the market based on key parameters, such as year-on-year (Y-o-Y) growth rates, to understand the predictability of the global hepatitis C treatment market and identify the right opportunities across the market.

The hepatitis C treatment market has been analyzed in terms of basis point share (BPS) to understand the individual segments’ relative contributions to market growth. This detailed level of information is important for identifying various key trends in the global hepatitis C treatment market.

Another key feature of this report is the analysis of key segments in terms of absolute dollar opportunity. This is overlooked while forecasting the market. However, absolute dollar opportunity is critical for evaluating the scope of opportunity that a provider can look to achieve, as well as to identify potential resources from a delivery perspective of the global hepatitis C treatment market. The overall absolute dollar opportunity along with the segmental split is mentioned in the report. To understand key growth segments in terms of growth and adoption for hepatitis C treatment globally, PMR has developed the hepatitis C treatment market attractiveness index to help providers identify real market opportunities.

  • Table 1 : Global Hepatitis C Treatment Market Size and Forecast by Drug Class (US$ Mn) (2016�2024)
  • Table 2 : Global Hepatitis C Treatment Market Size and Forecast by Distribution Channel (US$ Mn) (2016�2024)
  • Table 3 : Global Hepatitis C Treatment Market Size and Forecast by Region (US$ Mn) (2016�2024)
  • Table 4 : North America Hepatitis C Treatment Market Size and Forecast by Country (US$ Mn) (2016�2024)
  • Table 5 : North America Hepatitis C Treatment Market Size and Forecast by Drug Class (US$ Mn) (2016�2024)
  • Table 6 : North America Hepatitis C Treatment Market Size and Forecast by Distribution Channel (US$ Mn) (2016�2024)
  • Table 7 : Latin America Hepatitis C Treatment Market Size and Forecast by Country (US$ Mn) (2016�2024)
  • Table 8 : Latin America Hepatitis C Treatment Market Size and Forecast by Drug Class (US$ Mn) (2016�2024)
  • Table 9 : Latin America Hepatitis C Treatment Market Size and Forecast by Distribution Channel (US$ Mn) (2016�2024)
  • Table 10 : Europe Hepatitis C Treatment Market Size and Forecast by Country (US$ Mn) (2016�2024)
  • Table 11 : Europe Hepatitis C Treatment Market Size and Forecast by Drug Class (US$ Mn) (2016�2024)
  • Table 12 : Europe Hepatitis C Treatment Market Size and Forecast by Distribution Channel (US$ Mn) (2016�2024)
  • Table 13 : APAC Hepatitis C Treatment Market Size and Forecast by Country (US$ Mn) (2016�2024)
  • Table 14 : APAC Hepatitis C Treatment Market Size and Forecast by Drug Class (US$ Mn) (2016�2024)
  • Table 15 : APAC Hepatitis C Treatment Market Size and Forecast by Distribution Channel (US$ Mn) (2016�2024)
  • Table 16 : MEA Hepatitis C Treatment Market Size and Forecast by Country (US$ Mn) (2016�2024)
  • Table 17 : MEA Hepatitis C Treatment Market Size and Forecast by Drug Class (US$ Mn) (2016�2024)
  • Table 18 : MEA Hepatitis C Treatment Market Size and Forecast by Distribution Channel (US$ Mn) (2016�2024)
  • Figure 1 : Global Hepatitis C Treatment Market Value (US$ Mn) & Y-o-Y Growth (%), 2016-2024
  • Figure 2 : Global Hepatitis C Treatment Market Absolute $ Opportunity, 2016-2024
  • Figure 3 : Global Hepatitis C Treatment Market Share and BPS Analysis (%) By Drug Class, 2016 & 2024
  • Figure 4 : Global Hepatitis C Treatment Market Y-o-Y growth (%) By Drug Class, 2016-2024
  • Figure 5 : Global Hepatitis C Treatment Market Value (US$ Mn) Forecast (2016-2024) By HCV Protease Inhibitors
  • Figure 6 : Global Hepatitis C Treatment Market Absolute $ Opportunity by HCV Protease Inhibitors, 2016-2024
  • Figure 7 : Global Hepatitis C Treatment Market Value (US$ Mn) Forecast (2016-2024) By HCV Polymerase Inhibitors
  • Figure 8 : Global Hepatitis C Treatment Market Absolute $ Opportunity by HCV Polymerase Inhibitors, 2016-2024
  • Figure 9 : Global Hepatitis C Treatment Market Value (US$ Mn) Forecast (2016-2024) By HCV NS5A Inhibitors
  • Figure 10 : Global Hepatitis C Treatment Market Absolute $ Opportunity by HCV NS5A Inhibitors, 2016-2024
  • Figure 11 : Global Hepatitis C Treatment Market Value (US$ Mn) Forecast (2016-2024) By Combination Therapy
  • Figure 12 : Global Hepatitis C Treatment Market Absolute $ Opportunity by Combination Therapy, 2016-2024
  • Figure 13 : Global Hepatitis C Treatment Market Value (US$ Mn) Forecast (2016-2024) By Ledipasvir & Sofosbuvir Sub-segment
  • Figure 14 : Global Hepatitis C Treatment Market Value (US$ Mn) Forecast (2016-2024) By Ombitasvir, Paritaprevir, Ritonavir & Dasabuvir Sub-segment
  • Figure 15 : Global Hepatitis C Treatment Market Value (US$ Mn) Forecast (2016-2024) By Elbasvir & Grazoprevir Sub-segment
  • Figure 16 : Global Hepatitis C Treatment Market Value (US$ Mn) Forecast (2016-2024) By Others Sub-segment
  • Figure 17 : Global Hepatitis C Treatment Market Value (US$ Mn) Forecast (2016-2024) By Interferon and Antiviral
  • Figure 18 : Global Hepatitis C Treatment Market Absolute $ Opportunity by Interferon and Antiviral, 2016-2024
  • Figure 19 : Global Hepatitis C Treatment Market Value (US$ Mn) Forecast (2016-2024) By Peginterferon alfa-2a Sub-segment
  • Figure 20 : Global Hepatitis C Treatment Market Value (US$ Mn) Forecast (2016-2024) By Peginterferon alfa-2b Sub-segment
  • Figure 21 : Global Hepatitis C Treatment Market Value (US$ Mn) Forecast (2016-2024) By Ribavirin Sub-segment
  • Figure 22 : Global Hepatitis C Treatment Market Value (US$ Mn) Forecast (2016-2024) By Others Sub-segment
  • Figure 23 : Global Hepatitis C Treatment Market Attractiveness Analysis by Drug Class, 2016-2024
  • Figure 24 : Global Hepatitis C Treatment Market Share and BPS Analysis (%) By Distribution Channel, 2016 & 2024
  • Figure 25 : Global Hepatitis C Treatment Market Y-o-Y growth (%) By Distribution Channel, 2016-2024
  • Figure 26 : Global Hepatitis C Treatment Market Value (US$ Mn) Forecast (2016-2024) By Hospital Pharmacies Segment
  • Figure 27 : Global Hepatitis C Treatment Market Absolute $ Opportunity by Hospital Pharmacies Segment, 2016-2024
  • Figure 28 : Global Hepatitis C Treatment Market Value (US$ Mn) Forecast (2016-2024) By Retail Pharmacies Segment
  • Figure 29 : Global Hepatitis C Treatment Market Absolute $ Opportunity by Retail Pharmacies Segment, 2016-2024
  • Figure 30 : Global Hepatitis C Treatment Market Value (US$ Mn) Forecast (2016-2024) By Online Pharmacies Segment
  • Figure 31 : Global Hepatitis C Treatment Market Absolute $ Opportunity by Online Pharmacies, 2016-2024
  • Figure 32 : Global Hepatitis C Treatment Market Attractiveness Analysis by Distribution Channel, 2016-2024
  • Figure 33 : North America Hepatitis C Treatment Market Value (US$ Mn) Forecast (2016-2024)
  • Figure 34 : Latin America Hepatitis C Treatment Market Value (US$ Mn) Forecast (2016-2024)
  • Figure 35 : Europe Hepatitis C Treatment Market Value (US$ Mn) Forecast (2016-2024)
  • Figure 36 : APAC Hepatitis C Treatment Market Value (US$ Mn) Forecast (2016-2024)
  • Figure 37 : MEA Hepatitis C Treatment Market Value (US$ Mn) Forecast (2016-2024)
  • Figure 38 : Global Hepatitis C Treatment Market Attractiveness Analysis by Region, 2016-2024
  • Figure 39 : North America Hepatitis C Treatment Market Share and BPS Analysis (%) By Country, 2016 & 2024
  • Figure 40 : North America Hepatitis C Treatment Market Y-o-Y growth (%) By Country, 2016-2024
  • Figure 41 : The U.S Hepatitis C Treatment Market Value (US$ Mn) Forecast (2016-2024)
  • Figure 42 : The U.S Hepatitis C Treatment Market Absolute $ Opportunity, 2016-2024
  • Figure 43 : Canada Hepatitis C Treatment Market Value (US$ Mn) Forecast (2016-2024)
  • Figure 44 : Canada Hepatitis C Treatment Market Absolute $ Opportunity, 2016-2024
  • Figure 45 : North America Hepatitis C Treatment Market Attractiveness Analysis by Country, 2016-2024
  • Figure 46 : North America Hepatitis C Treatment Market Attractiveness Analysis by Drug Class, 2016-2024
  • Figure 47 : North America Hepatitis C Treatment Market Attractiveness Analysis by Distribution Channel, 2016-2024
  • Figure 48 : Latin America Hepatitis C Treatment Market Share and BPS Analysis (%) By Country, 2016 & 2024
  • Figure 49 : Latin America Hepatitis C Treatment Market Y-o-Y growth (%) By Country, 2016-2024
  • Figure 50 : Brazil Hepatitis C Treatment Market Value (US$ Mn) Forecast (2016-2024)
  • Figure 51 : Brazil Hepatitis C Treatment Market Absolute $ Opportunity, 2016-2024
  • Figure 52 : Mexico Hepatitis C Treatment Market Value (US$ Mn) Forecast (2016-2024)
  • Figure 53 : Mexico Hepatitis C Treatment Market Absolute $ Opportunity, 2016-2024
  • Figure 54 : Rest of Latin America Hepatitis C Treatment Market Value (US$ Mn) Forecast (2016-2024)
  • Figure 55 : Rest of Latin America Hepatitis C Treatment Market Absolute $ Opportunity, 2016-2024
  • Figure 56 : Latin America Hepatitis C Treatment Market Attractiveness Analysis by Country, 2016-2024
  • Figure 57 : Latin America Hepatitis C Treatment Market Attractiveness Analysis by Drug Class, 2016-2024
  • Figure 58 : Latin America Hepatitis C Treatment Market Attractiveness Analysis by Distribution Channel, 2016-2024
  • Figure 59 : Europe Hepatitis C Treatment Market Share and BPS Analysis (%) By Country, 2016 & 2024
  • Figure 60 : Europe Hepatitis C Treatment Market Y-o-Y growth (%) By Country, 2016-2024
  • Figure 61 : U.K. Hepatitis C Treatment Market Value (US$ Mn) Forecast (2016-2024)
  • Figure 62 : U.K. Hepatitis C Treatment Market Absolute $ Opportunity, 2016-2024
  • Figure 63 : France Hepatitis C Treatment Market Value (US$ Mn) Forecast (2016-2024)
  • Figure 64 : France Hepatitis C Treatment Market Absolute $ Opportunity, 2016-2024
  • Figure 65 : Germany Hepatitis C Treatment Market Value (US$ Mn) Forecast (2016-2024)
  • Figure 66 : Germany Hepatitis C Treatment Market Absolute $ Opportunity, 2016-2024
  • Figure 67 : Rest of Europe Hepatitis C Treatment Market Value (US$ Mn) Forecast (2016-2024)
  • Figure 68 : Rest of Europe Hepatitis C Treatment Market Absolute $ Opportunity, 2016-2024
  • Figure 69 : Europe Hepatitis C Treatment Market Attractiveness Analysis by Country, 2016-2024
  • Figure 70 : Europe Hepatitis C Treatment Market Attractiveness Analysis by Drug Class, 2016-2024
  • Figure 71 : Europe Hepatitis C Treatment Market Attractiveness Analysis by Distribution Channel, 2016-2024
  • Figure 72 : APAC Hepatitis C Treatment Market Share and BPS Analysis (%) By Country, 2016 & 2024
  • Figure 73 : APAC Hepatitis C Treatment Market Y-o-Y growth (%) By Country, 2016-2024
  • Figure 74 : Japan Hepatitis C Treatment Market Value (US$ Mn) Forecast (2016-2024)
  • Figure 75 : Japan Hepatitis C Treatment Market Absolute $ Opportunity, 2016-2024
  • Figure 76 : China Hepatitis C Treatment Market Value (US$ Mn) Forecast (2016-2024)
  • Figure 77 : China Hepatitis C Treatment Market Absolute $ Opportunity, 2016-2024
  • Figure 78 : Australia & New Zealand Hepatitis C Treatment Market Value (US$ Mn) Forecast (2016-2024)
  • Figure 79 : Australia & New Zealand Hepatitis C Treatment Market Absolute $ Opportunity, 2016-2024
  • Figure 80 : Rest of APAC Hepatitis C Treatment Market Value (US$ Mn) Forecast (2016-2024)
  • Figure 81 : Rest of APAC Hepatitis C Treatment Market Absolute $ Opportunity, 2016-2024
  • Figure 82 : APAC Hepatitis C Treatment Market Attractiveness Analysis by Country, 2016-2024
  • Figure 83 : APAC Hepatitis C Treatment Market Attractiveness Analysis by Drug Class, 2016-2024
  • Figure 84 : APAC Hepatitis C Treatment Market Attractiveness Analysis by Distribution Channel, 2016-2024
  • Figure 85 : MEA Hepatitis C Treatment Market Share and BPS Analysis (%) By Country, 2016 & 2024
  • Figure 86 : MEA Hepatitis C Treatment Market Y-o-Y growth (%) By Country, 2016-2024
  • Figure 87 : GCC Countries Hepatitis C Treatment Market Value (US$ Mn) Forecast (2016-2024)
  • Figure 88 : GCC Countries Hepatitis C Treatment Market Absolute $ Opportunity, 2016-2024
  • Figure 89 : South Africa Hepatitis C Treatment Market Value (US$ Mn) Forecast (2016-2024)
  • Figure 90 : South Africa Hepatitis C Treatment Market Absolute $ Opportunity, 2016-2024
  • Figure 91 : Rest of MEA Hepatitis C Treatment Market Value (US$ Mn) Forecast (2016-2024)
  • Figure 92 : Rest of MEA Hepatitis C Treatment Market Absolute $ Opportunity, 2016-2024
  • Figure 93 : MEA Hepatitis C Treatment Market Attractiveness Analysis by Country, 2016-2024
  • Figure 94 : MEA Hepatitis C Treatment Market Attractiveness Analysis by Drug Class, 2016-2024
  • Figure 95 : MEA Hepatitis C Treatment Market Attractiveness Analysis by Distribution Channel, 2016-2024

Persistence Market Research (PMR) is a third-platform research firm. Our research model is a unique collaboration of data analytics and market research methodology to help businesses achieve optimal performance.

To support companies in overcoming complex business challenges, we follow a multi-disciplinary approach. At PMR, we unite various data streams from multi-dimensional sources. By deploying real-time data collection, big data, and customer experience analytics, we deliver business intelligence for organization of all sizes.

Why BCC Research?

Every purchase provides access to:

  • Thousands of recently published reports from select publishers
  • Discounts of up to 50% on over 20,000 additional reports from all publishers
  • Our analysts and research concierge for all inquiries
CUSTOM RESEARCH

Need a custom data table, graph or complete report? Tell us more.

Contact Us
Share This Report